Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end-organ protection?
出版年份 2017 全文链接
标题
Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end-organ protection?
作者
关键词
-
出版物
HYPERTENSION RESEARCH
Volume 40, Issue 11, Pages 903-909
出版商
Springer Nature
发表日期
2017-07-06
DOI
10.1038/hr.2017.65
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MP248PERSEPHIN PROTECTS AGAINST CISPLATIN-INDUCED ACUTE KIDNEY INJURY
- (2017) Xiaoye Shen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Comparison of direct renin inhibitor and angiotensin II receptor blocker on clinic and ambulatory blood pressure profiles in hypertension with chronic kidney disease
- (2016) Kazushi Uneda et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
- Aliskiren and l-arginine treatments restore depressed baroreflex sensitivity and decrease oxidative stress in renovascular hypertension rats
- (2016) Vinicius Mengal et al. HYPERTENSION RESEARCH
- Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
- (2016) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular and Renal Outcomes of Renin–Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses
- (2016) Ferrán Catalá-López et al. PLOS MEDICINE
- Comparison of angiotensin-(1–7), losartan and their combination on atherosclerotic plaque formation in apolipoprotein E knockout mice
- (2015) Jianmin Yang et al. ATHEROSCLEROSIS
- AT2R Agonist, Compound 21, Is Reno-Protective Against Type 1 Diabetic Nephropathy
- (2015) C. Koulis et al. HYPERTENSION
- Aldosterone and abnormal left ventricular geometry in chronic kidney disease
- (2015) Cesare Cuspidi et al. HYPERTENSION RESEARCH
- The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy
- (2015) Atsuhisa Sato HYPERTENSION RESEARCH
- Plasma aldosterone and its relationship with left ventricular mass in hypertensive patients with early-stage chronic kidney disease
- (2015) Giuseppe Mulè et al. HYPERTENSION RESEARCH
- Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis
- (2015) Suetonia C Palmer et al. LANCET
- Atlas of tissue renin-angiotensin-aldosterone system in human: A transcriptomic meta-analysis
- (2015) Ali Nehme et al. Scientific Reports
- Statins and Renin-Angiotensin System Inhibitor Combination Treatment to Prevent Cardiovascular Disease
- (2014) Hae-Young Lee et al. CIRCULATION JOURNAL
- Angiotensin AT2 receptor stimulation is anti-inflammatory in lipopolysaccharide-activated THP-1 macrophages via increased interleukin-10 production
- (2014) Isha Dhande et al. HYPERTENSION RESEARCH
- Mutual amplification of corticosteroids and angiotensin systems in human vascular smooth muscle cells and carotid atheroma
- (2014) Hanène Ayari et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Combination Therapy as First-Line Treatment for Hypertension
- (2013) Michael H. Crawford American Journal of Cardiovascular Drugs
- ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis
- (2013) AC Simões e Silva et al. BRITISH JOURNAL OF PHARMACOLOGY
- Discovery and Characterization of Alamandine
- (2013) Roberto Queiroga Lautner et al. CIRCULATION RESEARCH
- An evolving story of angiotensin-II-forming pathways in rodents and humans
- (2013) Carlos Maria Ferrario et al. CLINICAL SCIENCE
- Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure
- (2013) Mihai Gheorghiade et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Angiotensin-(1–9) enhances stasis-induced venous thrombosis in the rat because of the impairment of fibrinolysis
- (2013) A Mogielnicki et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- The effect of AVE 0991, nebivolol and doxycycline on inflammatory mediators in an apoE-knockout mouse model of atherosclerosis
- (2013) Jacek Jawien et al. MEDICAL SCIENCE MONITOR
- Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
- (2013) H. Makani et al. BMJ-British Medical Journal
- Aliskiren: review of efficacy and safety data with focus on past and recent clinical trials
- (2013) Selçuk Şen et al. Therapeutic Advances in Chronic Disease
- The role of direct renin inhibitors in the treatment of the hypertensive diabetic patient
- (2013) Graziano Riccioni Therapeutic Advances in Endocrinology and Metabolism
- The 2012 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Acute and Chronic Heart Failure
- (2012) Robert S. McKelvie et al. CANADIAN JOURNAL OF CARDIOLOGY
- Hypertension
- (2012) Daniel T. Lackland CURRENT OPINION IN NEUROLOGY
- THE EFFECTS AND MECHANISM OF RESVERATROL ATTENUATING OXIDATIVE STRESS IN BALLOON INJURED RAT CAROTID ARTERY
- (2012) Jing Zhang et al. HEART
- Why Do We Need a Selective Angiotensin II Type 2 Receptor Agonist?
- (2012) Daniel Henrion HYPERTENSION
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alternative pathways for angiotensin II generation in the cardiovascular system
- (2011) C. Becari et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk
- (2011) Sheldon W. Tobe et al. CIRCULATION
- Pressor and Renal Hemodynamic Effects of the Novel Angiotensin A Peptide Are Angiotensin II Type 1A Receptor Dependent
- (2011) Rui Yang et al. HYPERTENSION
- Eplerenone Survival Benefits in Heart Failure Patients Post-Myocardial Infarction Are Independent From its Diuretic and Potassium-Sparing Effects
- (2011) Patrick Rossignol et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Randomized, Double-Blind, Placebo-Controlled Trial of Spironolactone on Carotid Intima-Media Thickness in Nondiabetic Hemodialysis Patients
- (2010) A. Vukusich et al. Clinical Journal of the American Society of Nephrology
- Mast cell chymase limits the cardiac efficacy of Ang I–converting enzyme inhibitor therapy in rodents
- (2010) Chih-Chang Wei et al. JOURNAL OF CLINICAL INVESTIGATION
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
- (2010) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meta-Analysis of Combined Therapy with Angiotensin Receptor Antagonists versus ACE Inhibitors Alone in Patients with Heart Failure
- (2010) Andrea Kuenzli et al. PLoS One
- Residual cardiovascular risk in treated hypertension and hyperlipidaemia: the PRIME Study
- (2009) J Blacher et al. JOURNAL OF HUMAN HYPERTENSION
- Oral Direct Renin Inhibition: Premise, Promise, and Potential Limitations of a New Antihypertensive Drug
- (2008) Moiz M. Shafiq et al. AMERICAN JOURNAL OF MEDICINE
- Safety and Tolerability of Angiotensin-Converting Enzyme Inhibitor Versus the Combination of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker in Patients With Left Ventricular Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2008) Rachid Lakhdar et al. JOURNAL OF CARDIAC FAILURE
- Genetics of the human renin angiotensin system
- (2008) Xavier Jeunemaitre JOURNAL OF MOLECULAR MEDICINE-JMM
- Thrombolytics for PE and right ventricular dysfunction
- (2008) Syed Wamique Yusuf et al. LANCET
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
- (2008) Johannes FE Mann et al. LANCET
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started